Ketamine is not an amphetamine. The two drugs belong to completely different chemical families, work through unrelated brain mechanisms, produce distinct effects, and carry different legal classifications. They share almost nothing in common beyond the fact that both are controlled substances with legitimate medical uses.
Different Chemical Families
Ketamine is an arylcyclohexylamine, a class of compounds built around a cyclohexane ring bonded to an aromatic ring. Its full chemical name is 2-(2-chlorophenyl)-2-(methylamino)-cyclohexanone. Amphetamine, by contrast, is a phenethylamine, a simpler structure based on a phenyl ring attached to an ethylamine chain. The two molecules look nothing alike, and their structural differences explain why they behave so differently in the body.
The amphetamine family includes a range of related drugs: dextroamphetamine, methamphetamine, lisdexamfetamine, and MDMA (ecstasy). Ketamine sits in an entirely separate group alongside substances like phencyclidine (PCP), which share its dissociative properties rather than any stimulant effect.
How They Work in the Brain
Ketamine and amphetamines target completely different neurotransmitter systems. Ketamine blocks NMDA receptors, which normally respond to glutamate, the brain’s primary excitatory chemical messenger. By blocking these receptors, ketamine disrupts normal signaling between neurons in a way that produces sedation, pain relief, and a sense of detachment from reality at low doses, and full unconsciousness at higher doses.
Amphetamines do something fundamentally different. They force the release of catecholamines, primarily dopamine and norepinephrine, from nerve terminals through a mechanism that essentially reverses the normal direction of neurotransmitter transporters. They also block the reuptake of these chemicals, keeping levels elevated in the spaces between neurons. The result is increased alertness, energy, focus, and euphoria. Where ketamine sedates and dissociates, amphetamines stimulate and sharpen attention.
What Each Drug Feels Like
The subjective experiences are nearly opposite. Ketamine produces dissociation, a feeling of being separated from your body and surroundings. At lower doses, people describe distorted perception of time and space. At higher doses, the experience can involve complete detachment from physical reality, sometimes called a “k-hole.” Pain perception drops significantly, which is why ketamine was originally developed as an anesthetic.
Amphetamines produce stimulation. Heart rate and blood pressure increase, attention sharpens, and energy rises. People feel more awake, more motivated, and often more talkative. At recreational doses, there is typically a strong sense of euphoria driven by the flood of dopamine. The two drug experiences are so different that confusing them in practice would be essentially impossible.
Medical Uses
Both drugs have legitimate medical applications, but for entirely different conditions. Ketamine is FDA-approved for induction and maintenance of general anesthesia. A nasal spray form of its mirror-image molecule, esketamine, is approved for treatment-resistant depression. Ketamine is also widely used off-label for pain management and as a rapid-acting treatment for severe depression and suicidal thinking.
Amphetamines are prescribed for ADHD, narcolepsy, and in some cases obesity. Common brand names include Adderall (an amphetamine combination), Dexedrine (dextroamphetamine), and Vyvanse (lisdexamfetamine). Methamphetamine even has a narrow FDA approval for ADHD, though it is rarely prescribed. The medical logic behind amphetamine prescriptions centers on their ability to increase dopamine and norepinephrine in brain circuits that regulate attention and wakefulness.
Long-Term Health Risks
The two drugs damage the body in different ways when misused. Chronic ketamine use is associated with severe bladder damage, a condition called ketamine-associated cystitis. Symptoms include blood in the urine, painful and frequent urination, urgency, and dramatically reduced bladder capacity. In heavy users, the damage can extend to the kidneys. Standard bladder medications do not relieve these symptoms, and in severe cases the damage can be irreversible.
Amphetamines primarily stress the cardiovascular system. Daily use raises blood pressure by an average of about 2 mmHg and heart rate by roughly four beats per minute. Those numbers sound small, but sustained over months or years they meaningfully increase the risk of stroke, heart attack, heart failure, and kidney failure. Cochrane review data shows these elevations persist across all time points studied, from short-term use of a few weeks through trials lasting two months or longer, suggesting the effects do not diminish with continued use.
Legal Classification
Under the U.S. Drug Enforcement Administration’s scheduling system, the two drugs occupy different categories. Amphetamines and methamphetamine are Schedule II substances, meaning they have a high potential for abuse and can cause severe psychological or physical dependence. Prescription stimulants like Adderall and Ritalin fall into this category.
Ketamine is classified as Schedule III, indicating a moderate to low potential for physical and psychological dependence, lower than Schedule II drugs. This difference in scheduling reflects the medical consensus that ketamine, while certainly subject to misuse, carries a somewhat lower dependence risk than amphetamines. Both drugs require a prescription for legal medical use, but the regulatory controls around amphetamines are stricter.